Dilazep

Dilazep

Clinical data
ATC code	C01DX10 (WHO)
Identifiers
IUPAC name 3-[4-[3-(3,4,5-Trimethoxybenzoyl)oxypropyl]-1,4-diazepan-1-yl]propyl 3,4,5-trimethoxybenzoate
PubChem CID	3074
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C31H44N2O10
Molar mass	604.69 g/mol

WikiDoc Resources for Dilazep
Articles
Most recent articles on Dilazep Most cited articles on Dilazep Review articles on Dilazep Articles on Dilazep in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Dilazep Images of Dilazep Photos of Dilazep Podcasts & MP3s on Dilazep Videos on Dilazep
Evidence Based Medicine
Cochrane Collaboration on Dilazep Bandolier on Dilazep TRIP on Dilazep
Clinical Trials
Ongoing Trials on Dilazep at Clinical Trials.gov Trial results on Dilazep Clinical Trials on Dilazep at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Dilazep NICE Guidance on Dilazep NHS PRODIGY Guidance FDA on Dilazep CDC on Dilazep
Books
Books on Dilazep
News
Dilazep in the news Be alerted to news on Dilazep News trends on Dilazep
Commentary
Blogs on Dilazep
Definitions
Definitions of Dilazep
Patient Resources / Community
Patient resources on Dilazep Discussion groups on Dilazep Patient Handouts on Dilazep Directions to Hospitals Treating Dilazep Risk calculators and risk factors for Dilazep
Healthcare Provider Resources
Symptoms of Dilazep Causes & Risk Factors for Dilazep Diagnostic studies for Dilazep Treatment of Dilazep
Continuing Medical Education (CME)
CME Programs on Dilazep
International
Dilazep en Espanol Dilazep en Francais
Business
Dilazep in the Marketplace Patents on Dilazep
Experimental / Informatics
List of terms related to Dilazep

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Dilazep is a vasodilator that acts as an adenosine reuptake inhibitor.